| Cutiss AG. (6/29/20). "Press Release: Series B Financing Oversubscribed. Cutiss Closes Series B Funding – Target of CHF 20 Million Oversubscribed". Zurich. |
2020-06-29 |
| Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. |
2020-06-17 |
| Lonza Group Ltd.. (6/5/20). "Press Release: Lonza Appoints New Chief Executive Officer". Basel. |
2020-06-05 |
| Delta 4 GmbH. (6/2/20). "Press Release: Delta 4 Announces Results Achieved with Drug Discovery Platform". Vienna. |
2020-06-02 |
| Proteomedix AG. (5/26/20). "Press Release: Proteomedix Appoints Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD as Medical Advisor". Zürich-Schlieren. |
2020-05-26 |
| Idorsia Ltd.. (5/20/20). "Press Release: Idorsia Successfully Completes the Offering of New Shares thereby Securing Funding for the Company’s Growth Plan". Allschwil. |
2020-05-20 |
| Proteomedix AG. (5/19/20). "Press Release: Analytical Performance of Proclarix Verified". Zürich-Schlieren. |
2020-05-19 |
| Idorsia Ltd.. (5/19/20). "Press Release: Idorsia Launches an Offering of New Shares to Fund the Company’s Growth plan". Allschwil. |
2020-05-19 |
| BaseLaunch (BaselArea.swiss). (5/15/20). "Press Release: Roche Becomes Founding Partner of BaseLaunch Phase II". Basel. |
2020-05-15 |
| Roche. (5/14/20). "Press Release: Roche to Present First Clinical Data on Novel Anti-TIGIT Cancer Immunotherapy Tiragolumab at ASCO". Basel. |
2020-05-14 |
| Endress+Hauser AG. (5/12/20). "Press Release: Endress+Hauser Sees Itself as Well Positioned. Group Increases Incoming Orders, Sales, Profits and Headcount in the 2019 Financial Year". |
2020-05-12 |
| Idorsia Ltd.. (5/12/20). "Press Release: Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy". San Diego, CA & Allschwil. |
2020-05-12 |
| Dyno Therapeutics, Inc.. (5/11/20). "Press Release: Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology". Cambridge, MA. |
2020-05-11 |
| ADC Therapeutics S.A.. (5/11/20). "Press Release: ADC Therapeutics Announces Launch of Initial Public Offering". Lausanne. |
2020-05-11 |
| CRISPR Therapeutics AG. (5/11/20). "Press Release: CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the Treatment of Severe Hemoglobinopathies". Zug, Cambridge, MA |
2020-05-11 |
| ADC Therapeutics S.A.. (5/1/20). "Press Release: ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield". Lausanne. |
2020-05-01 |
| Lonza Ltd.. (5/1/20). "Press Release: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) against Novel Coronavirus". Cambridge, MA & Basel. |
2020-05-01 |
| Syncona Ltd.. (4/30/20). "Press Release: Danny Bar-Zohar Joins Syncona as Partner". |
2020-04-30 |
| Biognosys AG. (4/28/20). "Press Release: Gustave Roussy and Biognosys Announce Partnership". Schlieren & Villejuif. |
2020-04-28 |
| Genedata AG. (4/28/20). "Press Release: Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection". Basel. |
2020-04-28 |
| ADC Therapeutics S.A.. (4/27/20). "Press Release: ADC Therapeutics Appoints Victor Sandor, M.D., to Its Board of Directors". Lausanne. |
2020-04-27 |
| ADC Therapeutics S.A.. (4/24/20). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. |
2020-04-24 |
| FoRx Therapeutics AG. (4/22/20). "Press Release: FoRx Therapeutics AG Raises EUR 10 Million Seed Round". Basel. |
2020-04-22 |
| Lunaphore Technologies S.A.. (4/21/20). "Press Release: Lunaphore Receives Additional CHF 2M in Series C2 Financing, Bringing Total Series C Round to CHF 25M". Lausanne. |
2020-04-21 |
| ADC Therapeutics S.A.. (4/21/20). "Press Release: ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer". Lausanne. |
2020-04-21 |
| MOMA Therapeutics. (4/15/20). "Press Release: MOMA Therapeutics – Drugging the Molecular Machines that Underlie Human Disease". |
2020-04-15 |
| Arrakis Therapeutics, Inc.. (4/8/20). "Press Release: Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform". Waltham, MA. |
2020-04-08 |
| Sophia Genetics S.A.. (4/8/20). "Press Release: Sophia Genetics Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer". Lausanne & Boston, MA. |
2020-04-08 |
| Roche. (4/7/20). "Press Release: Roche Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)". Basel. |
2020-04-07 |
| Neurimmune AG. (4/1/20). "Press Release: Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of Covid-19". Zurich & Munich. |
2020-04-01 |
| Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich). |
2020-03-30 |
| Sophia Genetics S.A.. (3/26/20). "Press Release: Sophia Genetics and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic". Lausanne & Boston, MA. |
2020-03-26 |
| SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. |
2020-03-26 |
| Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. |
2020-03-25 |
| Evotec SE. (3/25/20). "Press Release: Evotec Partner Forge Enters into Collaboration with Roche to Develop Novel Antibiotic". San Diego, CA. |
2020-03-25 |
| Debiopharm International SA. (3/25/20). "Press Release: Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-licensing Agreement of 3B Pharmaceutical’s Targeted CAIX Radiotherapy". Lausanne. |
2020-03-25 |
| Roche. (3/24/20). "Press Release: Roche Response to COVID-19 Pandemic". Basel. |
2020-03-24 |
| Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. |
2020-03-23 |
| AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. |
2020-03-23 |
| Roche. (3/23/20). "Press Release: Roche Announces Venclexta/Venclyxto Combination Improved Overall Survival in People with Previously Untreated Acute Myeloid Leukaemia". Basel. |
2020-03-23 |
| ADC Therapeutics S.A.. (3/19/20). "Press Release: ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company". Lausanne. |
2020-03-19 |
| Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo. |
2020-03-10 |
| Numab Therapeutics AG. (3/9/20). "Press Release: Numab Therapeutics Closes Series B Financing at CHF 22M to Advance Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil (Zurich). |
2020-03-09 |
| Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. |
2020-03-05 |
| Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. |
2020-03-04 |
| MGI Tech Co., Ltd.. (2/27/20). "Press Release: MGI and Sophia Genetics Partner to Provide Solutions to Interpret Genomic Data". San José, CA. |
2020-02-27 |
| Nouscom AG. (2/26/20). "Press Release: Nouscom Strengthens Its Management Team. Marina Udier, PhD Appointed as Chief Executive Officer and Patricia Delaite, MD Appointed as Chief Medical Officer". Basel. |
2020-02-26 |
| Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel. |
2020-02-26 |
| CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA. |
2020-02-26 |
| Twist Bioscience Corporation. (2/26/20). "Press Release: Twist Bioscience and Sophia Genetics Collaborate to Offer Optimized Genomic Solutions". South San Francisco, CA. |
2020-02-26 |
| ProBioGen AG. (2/25/20). "Press Release: ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Schlieren. |
2020-02-25 |
| Sophia Genetics S.A.. (2/20/20). "Press Release: Sophia Genetics’ Board of Directors Elects Troy Cox as New Chairman". Lausanne & Boston, MA. |
2020-02-20 |
| Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. |
2020-02-17 |
| Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. |
2020-02-13 |
| CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA. |
2020-02-12 |
| Proteomedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür |
2020-02-11 |
| Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. |
2020-02-10 |
| Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. |
2020-02-06 |
| Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. |
2020-02-06 |
| Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. |
2020-02-05 |
| BenchSci. (2/4/20). "Press Release: BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend". Toronto. |
2020-02-04 |
| Stalicla S.A.. (2/3/20). "Press Release: Swiss Biotech Stalicla Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A". Geneva. |
2020-02-03 |
| Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. |
2020-02-03 |
| GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva. |
2020-01-31 |
| Gilead Sciences, Inc.. (1/30/20). "Press Release: Sandra Horning, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA. |
2020-01-30 |
| Merck KGaA. (1/27/20). "Press Release: Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland". Corsier-sur-Vevey. |
2020-01-27 |
| Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. |
2020-01-24 |
| Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil. |
2020-01-23 |
| Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA. |
2020-01-15 |
| Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. |
2020-01-13 |
| NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. |
2020-01-10 |
| Proteomedix AG. (1/10/20). "Press Release: Proteomedix Appoints Helge Lubenow as New CEO". Zürich-Schlieren. |
2020-01-10 |
| Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. |
2020-01-09 |
| Novadiscovery S.A.S.. (1/9/20). "Press Release: Novadiscovery Raises Series A Financing to Scale Its in silico Clinical Trial Platform – Debiopharm Leads the Round with EUR 5 Million". |
2020-01-09 |
| ProBioGen AG. (1/8/20). "Press Release: ProBioGen Inks Next Commercial GlymaxX License with Roche. ADCC-enhancement for Innovative Cancer Therapy". Berlin. |
2020-01-08 |
| BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. |
2020-01-08 |
| VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. |
2020-01-07 |
| Velabs Therapeutics GmbH. (1/7/20). "Press Release: Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics". Heidelberg & Jena. |
2020-01-07 |
| Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. |
2019-12-23 |
| Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris. |
2019-12-18 |
| BC Platforms. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. |
2019-12-18 |
| Roche. (12/17/19). "Press Release: Roche Concludes Acquisition of Spark Therapeutics, Inc. to Strengthen Presence in GeneTherapy". Basel. |
2019-12-17 |
| Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. |
2019-12-17 |
| Resistell AG. (12/17/19). "Press Release: Resistell AG Closes CHF 3.5M Series A Financing Round". |
2019-12-17 |
| Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai. |
2019-12-12 |
| Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. |
2019-12-12 |
| Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). |
2019-12-10 |
| ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren. |
2019-12-10 |
| Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. |
2019-12-10 |
| ObsEva S.A.. (12/9/19). "Press Release: ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix". Geneva & Boston, MA. |
2019-12-09 |
| Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. |
2019-12-09 |
| BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
| Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. |
2019-12-03 |
| Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. |
2019-12-02 |
| Lonza Group Ltd.. (11/26/19). "Press Release: Lonza and Dinaqor Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies". Basel & Pfäffikon. |
2019-11-26 |
| MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. |
2019-11-26 |
| Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. |
2019-11-25 |
| GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. |
2019-11-25 |
| Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel. |
2019-11-24 |
| Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. |
2019-11-22 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
